|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||16.35 mL||81.77 mL||163.54 mL|
|0.5 mM||3.27 mL||16.35 mL||32.71 mL|
|1 mM||1.64 mL||8.18 mL||16.35 mL|
|5 mM||0.33 mL||1.64 mL||3.27 mL|
*The above data is based on the productmolecular weight 611.48. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
Dabrafenib is a potent and selective inhibitor of B-RAF protein kinase carrying V600E mutation, currently in clinical trial.
KM 11060 corrects F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane (~75%) and Inhibits PDE5 activit…
TAK-632 is a potent pan-RAF inhibitor with favorable in vitro activity (BRAF(V600E) IC50, 2.4 nM; BRAF(wt), 8.3 nM; CRAF, 1.4 nM; pMEK (A37…
NVP-BHG712 is a selective inhibitor of EphB4 kinase that exhibits selectivity for EphB4 over more than 40 other kinases in vitro, including …
Dabigatran ethyl ester, which is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.
LGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.